Chemoinformaics analysis of 3,6,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)chromen-4-one
| Molecular Weight | 1897.59 | nRot | 10 |
| Heavy Atom Molecular Weight | 1825.01 | nRig | 18 |
| Exact Molecular Weight | 1896.35 | nRing | 18 |
| Solubility: LogS | -3.675 | nHRing | 6 |
| Solubility: LogP | 2.318 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 18 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 210 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 138 | No. of Aromatic Carbocycles | 12 |
| nHetero | 42 | No. of Aromatic Hetero Cycles | 6 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 72 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 96 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 96 |
| No. of Oxygen atom | 42 | No. of Arom Bond | 102 |
| nHA | 42 | APOL | 242.013 |
| nHD | 26 | BPOL | 94.7989 |
| QED | 0.535 |
| Synth | 2.447 |
| Natural Product Likeliness | 1.098 |
| NR-PPAR-gamma | 0.933 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.009 |
| Pgp-sub | 0.008 |
| HIA | 0.02 |
| CACO-2 | -5.016 |
| MDCK | 0.0000107 |
| BBB | 0.009 |
| PPB | 0.927254 |
| VDSS | 0.589 |
| FU | 0.10252 |
| CYP1A2-inh | 0.925 |
| CYP1A2-sub | 0.534 |
| CYP2c19-inh | 0.054 |
| CYP2c19-sub | 0.05 |
| CYP2c9-inh | 0.509 |
| CYP2c9-sub | 0.605 |
| CYP2d6-inh | 0.219 |
| CYP2d6-sub | 0.287 |
| CYP3a4-inh | 0.328 |
| CYP3a4-sub | 0.11 |
| CL | 10.158 |
| T12 | 0.927 |
| hERG | 0.039 |
| Ames | 0.736 |
| ROA | 0.137 |
| SkinSen | 0.932 |
| Carcinogencity | 0.084 |
| EI | 0.932 |
| Respiratory | 0.091 |
| NR-Aromatase | 0.9 |
| Antiviral | Yes |
| Prediction | 0.649733 |